Tech Company M&A Transactions
Prism Pharmaceuticals Acquisition
Prism Pharmaceuticals was acquired by Baxter International. The transaction was announced on 4/18/2011. Baxter International said the transaction price was $338 million.
Transaction Overview
Company Name
Acquired By
Announced On
4/18/2011
Transaction Type
M&A
Amount
$338,000,000
M&A Terms
The terms of the agreement include a total consideration of up to $338 million, consisting of an upfront cash payment of $170 million at closing and up to $168 million in future sales-based milestone payments.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1016 West Ninth Avenue 130
King of Prussia, PA 19406
USA
King of Prussia, PA 19406
USA
Phone
Website
Email Address
Overview
Prism will become a leading specialty pharmaceutical company committed to developing and commercializing acute care cardiovascular products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Warren Copper
Chief Financial Officer
Stanley Musial
Chief Operating Officer
Kathleen DeLawrence
VP - Regulatory Affairs
Daniel Cushing
Browse more venture capital transactions:
Prev: 4/18/2011: GMZ Energy venture capital transaction
Next: 4/18/2011: Everyday Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs